Cargando…
Lipid Nanoparticles-Encapsulated YF4: A Potential Therapeutic Oral Peptide Delivery System for Hypertension Treatment
Drugs are administered orally in the clinical treatment of hypertension. Antihypertensive peptides have excellent angiotensin converting enzyme inhibitors activity in vitro. However, the poor oral bioavailability and therapeutic effect of antihypertensive peptides were mainly caused by rapid degrada...
Autores principales: | Zhao, Shengnan, Li, Jinhua, Zhou, Yang, Huang, Lingjing, Li, Yanfei, Xu, Juanjuan, Fu, Chunmei, Guo, Xia, Yang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401629/ https://www.ncbi.nlm.nih.gov/pubmed/30873021 http://dx.doi.org/10.3389/fphar.2019.00102 |
Ejemplares similares
-
Enhanced Antitumor Activity of Lidocaine Nanoparticles Encapsulated by a Self-Assembling Peptide
por: Yang, Yang, et al.
Publicado: (2022) -
Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route
por: Chen, Fengqian, et al.
Publicado: (2022) -
Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer
por: Peng, Jianqing, et al.
Publicado: (2021) -
Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
por: Feitosa, Renata Carvalho, et al.
Publicado: (2019) -
Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
por: Tao, Yaoye, et al.
Publicado: (2020)